No Data
No Data
No Data
No Data
No Data
Berry Gene (000710.SZ): No big data artificial intelligence business yet
Gelonghui, April 30 | Berry Gene (000710.SZ) said on the investor interactive platform that the company is committed to the comprehensive transformation of gene sequencing technology to clinical application, focusing on reproductive health, genetic disease testing, tumor testing, scientific and technological services, etc., and there is no big data artificial intelligence business yet.
Gelonghui FinanceApr 30 06:14 ET
Berry Gene (000710.SZ): Committed to the comprehensive transformation of gene sequencing technology to clinical application, focusing on reproductive health, genetic disease testing, tumor testing, scientific and technological services
Gelonghui, April 30 | Berry Gene (000710.SZ) said on the investor interactive platform that the company is committed to the comprehensive transformation of gene sequencing technology to clinical application, focusing on reproductive health, genetic disease testing, tumor testing, scientific and technological services; for basic research services, the company has now established dozens of research product types covering library sequencing, animal and plant genome De novo, animal and plant genome re-sequencing, human genome re-sequencing, transcriptional regulation, single-cell transcriptomics, spatial proteomics, microbiology, etc. in cancer research, Genetic disease research, animal and plant research
Gelonghui FinanceApr 30 06:13 ET
Berry Gene (000710.SZ) announced its 2023 annual results, net loss of 427 million yuan, and loss increased
Berry Gene (000710.SZ) released its 2023 annual report. The company's revenue was 1.151 billion yuan,...
Zhitong FinanceApr 24 08:09 ET
The Market Doesn't Like What It Sees From Berry Genomics Co.,Ltd's (SZSE:000710) Revenues Yet As Shares Tumble 40%
Berry Genomics Co.,Ltd (SZSE:000710) shares have had a horrible month, losing 40% after a relatively good period beforehand. The drop over the last 30 days has capped off a tough year for sharehold
Simply Wall StApr 20 20:50 ET
China Non-Invasive Prenatal Testing Market Research Report 2024-2032 Featuring Basetra, Berry Genomics, and BGI Diagnosis
Yahoo FinanceMar 29 05:17 ET
China Genetic Testing Market Report 2024-2032 Featuring BGI, Berry Genomics, Daan Gene, WuXi NextCODE, Annoroad Gene Technology, and WuXi PharmaTech - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "China Genetic Testing Market Report by Test Type, Disease, Technology, Service Provider, Testing Sample 2024-2032" report has been added to ResearchAndMarkets.com's offer
BusinesswireMar 27 09:13 ET
No Data
No Data